Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ALAB vs MRVL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ALAB
Astera Labs, Inc. Common Stock

Semiconductors

TechnologyNASDAQ • US
Market Cap$36.71B
5Y Perf.+188.5%
MRVL
Marvell Technology, Inc.

Semiconductors

TechnologyNASDAQ • US
Market Cap$146.14B
5Y Perf.+133.0%

ALAB vs MRVL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ALAB logoALAB
MRVL logoMRVL
IndustrySemiconductorsSemiconductors
Market Cap$36.71B$146.14B
Revenue (TTM)$1.00B$8.19B
Net Income (TTM)$268M$2.67B
Gross Margin76.0%51.0%
Operating Margin22.4%16.1%
Forward P/E86.5x44.0x
Total Debt$35M$4.47B
Cash & Equiv.$168M$2.64B

ALAB vs MRVLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ALAB
MRVL
StockMar 24May 26Return
Astera Labs, Inc. C… (ALAB)100288.5+188.5%
Marvell Technology,… (MRVL)100233.0+133.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: ALAB vs MRVL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MRVL leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Astera Labs, Inc. Common Stock is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
ALAB
Astera Labs, Inc. Common Stock
The Growth Play

ALAB is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 115.1%, EPS growth 290.6%, 3Y rev CAGR 120.2%
  • Lower volatility, beta 2.99, Low D/E 2.6%, current ratio 10.24x
  • 115.1% revenue growth vs MRVL's 42.1%
Best for: growth exposure and sleep-well-at-night
MRVL
Marvell Technology, Inc.
The Income Pick

MRVL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 2.21, yield 0.1%
  • 16.9% 10Y total return vs ALAB's 247.7%
  • Beta 2.21, yield 0.1%, current ratio 2.01x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthALAB logoALAB115.1% revenue growth vs MRVL's 42.1%
ValueMRVL logoMRVLLower P/E (44.0x vs 86.5x)
Quality / MarginsMRVL logoMRVL32.6% margin vs ALAB's 26.7%
Stability / SafetyMRVL logoMRVLBeta 2.21 vs ALAB's 2.99
DividendsMRVL logoMRVL0.1% yield; the other pay no meaningful dividend
Momentum (1Y)ALAB logoALAB+198.9% vs MRVL's +172.7%
Efficiency (ROA)ALAB logoALAB18.3% ROA vs MRVL's 12.6%, ROIC 12.3% vs 6.0%

ALAB vs MRVL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ALABAstera Labs, Inc. Common Stock
FY 2025
Reportable Segment
100.0%$853M
MRVLMarvell Technology, Inc.
FY 2025
Data Center
72.2%$4.2B
Enterprise Networking
10.9%$626M
Carrier Infrastructure
5.9%$338M
Automotive And Industrial
5.6%$322M
Consumer
5.5%$316M

ALAB vs MRVL — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMRVLLAGGINGALAB

Income & Cash Flow (Last 12 Months)

ALAB leads this category, winning 5 of 6 comparable metrics.

MRVL is the larger business by revenue, generating $8.2B annually — 8.2x ALAB's $1.0B. MRVL is the more profitable business, keeping 32.6% of every revenue dollar as net income compared to ALAB's 26.7%. On growth, ALAB holds the edge at +93.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
RevenueTrailing 12 months$1.0B$8.2B
EBITDAEarnings before interest/tax$230M$2.3B
Net IncomeAfter-tax profit$268M$2.7B
Free Cash FlowCash after capex$343M$1.4B
Gross MarginGross profit ÷ Revenue+76.0%+51.0%
Operating MarginEBIT ÷ Revenue+22.4%+16.1%
Net MarginNet income ÷ Revenue+26.7%+32.6%
FCF MarginFCF ÷ Revenue+34.2%+17.0%
Rev. Growth (YoY)Latest quarter vs prior year+93.4%+22.1%
EPS Growth (YoY)Latest quarter vs prior year+144.4%+100.0%
ALAB leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

MRVL leads this category, winning 6 of 6 comparable metrics.

At 55.0x trailing earnings, MRVL trades at a 69% valuation discount to ALAB's 176.8x P/E. On an enterprise value basis, MRVL's 111.9x EV/EBITDA is more attractive than ALAB's 202.9x.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
Market CapShares × price$36.7B$146.1B
Enterprise ValueMkt cap + debt − cash$36.6B$148.0B
Trailing P/EPrice ÷ TTM EPS176.80x54.97x
Forward P/EPrice ÷ next-FY EPS est.86.46x44.00x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple202.94x111.85x
Price / SalesMarket cap ÷ Revenue43.06x17.83x
Price / BookPrice ÷ Book value/share28.40x10.26x
Price / FCFMarket cap ÷ FCF130.30x104.65x
MRVL leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

ALAB leads this category, winning 7 of 8 comparable metrics.

ALAB delivers a 20.3% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $19 for MRVL. ALAB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRVL's 0.31x. On the Piotroski fundamental quality scale (0–9), MRVL scores 7/9 vs ALAB's 5/9, reflecting strong financial health.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
ROE (TTM)Return on equity+20.3%+19.4%
ROA (TTM)Return on assets+18.3%+12.6%
ROICReturn on invested capital+12.3%+6.0%
ROCEReturn on capital employed+14.7%+7.1%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.03x0.31x
Net DebtTotal debt minus cash-$132M$1.8B
Cash & Equiv.Liquid assets$168M$2.6B
Total DebtShort + long-term debt$35M$4.5B
Interest CoverageEBIT ÷ Interest expense15.17x
ALAB leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

MRVL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MRVL five years ago would be worth $37,944 today (with dividends reinvested), compared to $34,772 for ALAB. Over the past 12 months, ALAB leads with a +198.9% total return vs MRVL's +172.7%. The 3-year compound annual growth rate (CAGR) favors MRVL at 60.5% vs ALAB's 51.5% — a key indicator of consistent wealth creation.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
YTD ReturnYear-to-date+20.1%+88.9%
1-Year ReturnPast 12 months+198.9%+172.7%
3-Year ReturnCumulative with dividends+247.7%+313.7%
5-Year ReturnCumulative with dividends+247.7%+279.4%
10-Year ReturnCumulative with dividends+247.7%+1692.2%
CAGR (3Y)Annualised 3-year return+51.5%+60.5%
MRVL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

MRVL leads this category, winning 2 of 2 comparable metrics.

MRVL is the less volatile stock with a 2.21 beta — it tends to amplify market swings less than ALAB's 2.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MRVL currently trades 97.6% from its 52-week high vs ALAB's 82.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
Beta (5Y)Sensitivity to S&P 5002.99x2.21x
52-Week HighHighest price in past year$262.90$172.98
52-Week LowLowest price in past year$63.40$53.78
% of 52W HighCurrent price vs 52-week peak+82.0%+97.6%
RSI (14)Momentum oscillator 0–10066.474.9
Avg Volume (50D)Average daily shares traded5.0M24.3M
MRVL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ALAB as "Buy" and MRVL as "Buy". Consensus price targets imply -6.8% upside for ALAB (target: $201) vs -23.2% for MRVL (target: $130). MRVL is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.

MetricALAB logoALABAstera Labs, Inc.…MRVL logoMRVLMarvell Technolog…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$201.13$129.52
# AnalystsCovering analysts1572
Dividend YieldAnnual dividend ÷ price+0.1%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.24
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

MRVL leads in 3 of 6 categories (Valuation Metrics, Total Returns). ALAB leads in 2 (Income & Cash Flow, Profitability & Efficiency).

Best OverallMarvell Technology, Inc. (MRVL)Leads 3 of 6 categories
Loading custom metrics...

ALAB vs MRVL: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ALAB or MRVL a better buy right now?

For growth investors, Astera Labs, Inc.

Common Stock (ALAB) is the stronger pick with 115. 1% revenue growth year-over-year, versus 42. 1% for Marvell Technology, Inc. (MRVL). Marvell Technology, Inc. (MRVL) offers the better valuation at 55. 0x trailing P/E (44. 0x forward), making it the more compelling value choice. Analysts rate Astera Labs, Inc. Common Stock (ALAB) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ALAB or MRVL?

On trailing P/E, Marvell Technology, Inc.

(MRVL) is the cheapest at 55. 0x versus Astera Labs, Inc. Common Stock at 176. 8x. On forward P/E, Marvell Technology, Inc. is actually cheaper at 44. 0x.

03

Which is the better long-term investment — ALAB or MRVL?

Over the past 5 years, Marvell Technology, Inc.

(MRVL) delivered a total return of +279. 4%, compared to +247. 7% for Astera Labs, Inc. Common Stock (ALAB). Over 10 years, the gap is even starker: MRVL returned +1692% versus ALAB's +247. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ALAB or MRVL?

By beta (market sensitivity over 5 years), Marvell Technology, Inc.

(MRVL) is the lower-risk stock at 2. 21β versus Astera Labs, Inc. Common Stock's 2. 99β — meaning ALAB is approximately 35% more volatile than MRVL relative to the S&P 500. On balance sheet safety, Astera Labs, Inc. Common Stock (ALAB) carries a lower debt/equity ratio of 3% versus 31% for Marvell Technology, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ALAB or MRVL?

By revenue growth (latest reported year), Astera Labs, Inc.

Common Stock (ALAB) is pulling ahead at 115. 1% versus 42. 1% for Marvell Technology, Inc. (MRVL). On earnings-per-share growth, the picture is similar: Marvell Technology, Inc. grew EPS 401. 0% year-over-year, compared to 290. 6% for Astera Labs, Inc. Common Stock. Over a 3-year CAGR, ALAB leads at 120. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ALAB or MRVL?

Marvell Technology, Inc.

(MRVL) is the more profitable company, earning 32. 6% net margin versus 25. 7% for Astera Labs, Inc. Common Stock — meaning it keeps 32. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALAB leads at 20. 3% versus 16. 1% for MRVL. At the gross margin level — before operating expenses — ALAB leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ALAB or MRVL more undervalued right now?

On forward earnings alone, Marvell Technology, Inc.

(MRVL) trades at 44. 0x forward P/E versus 86. 5x for Astera Labs, Inc. Common Stock — 42. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALAB: -6. 8% to $201. 13.

08

Which pays a better dividend — ALAB or MRVL?

In this comparison, MRVL (0.

1% yield) pays a dividend. ALAB does not pay a meaningful dividend and should not be held primarily for income.

09

Is ALAB or MRVL better for a retirement portfolio?

For long-horizon retirement investors, Marvell Technology, Inc.

(MRVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1692% 10Y return). Astera Labs, Inc. Common Stock (ALAB) carries a higher beta of 2. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MRVL: +1692%, ALAB: +247. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ALAB and MRVL?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ALAB

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 46%
  • Net Margin > 16%
Run This Screen
Stocks Like

MRVL

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 19%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ALAB and MRVL on the metrics below

Revenue Growth>
%
(ALAB: 93.4% · MRVL: 22.1%)
Net Margin>
%
(ALAB: 26.7% · MRVL: 32.6%)
P/E Ratio<
x
(ALAB: 176.8x · MRVL: 55.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.